Join our community of smart investors

AstraZeneca and the fight against virus variants

London's largest pharma group said it would tackle Covid-19 mutations as it reported full-year numbers
AstraZeneca and the fight against virus variants
  • AstraZeneca plans to adapt its vaccine to protect against new variants
  • The group said in December it would buy Alexion Pharmaceuticals, bulking up while peer GSK splits itself in two

To continue reading...
OR
Register for free
Read 3 articles for free each month
* Excl. premium articles
Have an account? Sign in